114 related articles for article (PubMed ID: 38073443)
1. Novel Pathways between Invasiveness Modulators in Breast Cancer Single Cells.
Eliceiri GL
Crit Rev Eukaryot Gene Expr; 2024; 34(2):73-75. PubMed ID: 38073443
[TBL] [Abstract][Full Text] [Related]
2. Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression.
Lim JP; Nair S; Shyamasundar S; Chua PJ; Muniasamy U; Matsumoto K; Gunaratne J; Bay BH
Cancer Lett; 2019 Jun; 452():119-131. PubMed ID: 30905819
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA-mediated downregulation of beta-catenin inhibits invasion and migration of colon cancer cells in vitro.
Han J; Gao B; Jin X; Xu Z; Li Z; Sun Y; Song B
Med Sci Monit; 2012 Jul; 18(7):BR273-80. PubMed ID: 22739727
[TBL] [Abstract][Full Text] [Related]
4. Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.
Goyal A; Martin TA; Mansel RE; Jiang WG
World J Surg Oncol; 2008 Jun; 6():56. PubMed ID: 18547424
[TBL] [Abstract][Full Text] [Related]
5. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
Rao Y; Wang H; Fan L; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
Zhang S; Da L; Yang X; Feng D; Yin R; Li M; Zhang Z; Jiang F; Xu L
Toxicol Lett; 2014 Mar; 225(2):201-7. PubMed ID: 24374173
[TBL] [Abstract][Full Text] [Related]
7. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
8. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target.
Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P
Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.
Kaur J; Sawhney M; DattaGupta S; Shukla NK; Srivastava A; Walfish PG; Ralhan R
PLoS One; 2013; 8(6):e67361. PubMed ID: 23840677
[TBL] [Abstract][Full Text] [Related]
11. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
12. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
[TBL] [Abstract][Full Text] [Related]
13. Effects of HMGA2 gene downregulation by siRNA on lung carcinoma cell migration in A549 cell lines.
Naghizadeh S; Mansoori B; Mohammadi A; Kafil HS; Mousavi Z; Sakhinia E; Baradaran B
J Cell Biochem; 2019 Apr; 120(4):5024-5032. PubMed ID: 30317663
[TBL] [Abstract][Full Text] [Related]
14. P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer.
Sun L; Hu H; Peng L; Zhou Z; Zhao X; Pan J; Sun L; Yang Z; Ran Y
Am J Pathol; 2011 Jul; 179(1):380-90. PubMed ID: 21703417
[TBL] [Abstract][Full Text] [Related]
15. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.
Vijaya Kumar A; Salem Gassar E; Spillmann D; Stock C; Sen YP; Zhang T; Van Kuppevelt TH; Hülsewig C; Koszlowski EO; Pavao MS; Ibrahim SA; Poeter M; Rescher U; Kiesel L; Koduru S; Yip GW; Götte M
Int J Cancer; 2014 Dec; 135(11):2579-92. PubMed ID: 24752740
[TBL] [Abstract][Full Text] [Related]
16. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
17. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
Li S; Jiao J; Lu Z; Zhang M
Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.
Lapyckyj L; Castillo LF; Matos ML; Gabrielli NM; Lüthy IA; Vazquez-Levin MH
J Cell Physiol; 2010 Mar; 222(3):596-605. PubMed ID: 19957299
[TBL] [Abstract][Full Text] [Related]
19. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
[TBL] [Abstract][Full Text] [Related]
20. MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin/β-catenin signaling pathway.
Wang Q; Qi C; Min P; Wang Y; Ye F; Xia T; Zhang Y; Du J
Cell Commun Signal; 2022 Sep; 20(1):136. PubMed ID: 36064550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
